alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › case-control

case-control

6 studies tagged case-control, dated 2017-01-01 to 2023-11-11. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study 2023-11-11
  2. Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline 2023-06-13
  3. Associations of risk genes with onset age and plasma biomarkers of Alzheimer's disease: a large case-control study in mainland China 2022-01-09

Studies

6 studies carry this tag.

Date range

2017 to 2023

Top journals

  • Journal of Alzheimer's disease : JAD 2
  • Alzheimer's research & therapy 1
  • Brain communications 1
  • Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1
  • PloS one 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Alzheimer's research & therapy 2023-11-11 Biomarkers

    In community and clinical settings, SCC predict both dementia and depression in the absence of dementia.

  2. Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Brain communications 2023-06-13 Biomarkers

    Relative to controls, greater Alzheimer's disease pathology (lower amyloid-β 42 /amyloid-β 40 , higher phosphorylated-tau-181) and synaptic degeneration (neurogranin) biomarker concentrations were associated with more adverse white matter metrics (e.g. lower neurite density, higher mean diffusivity) in patients with asthma.

  3. Associations of risk genes with onset age and plasma biomarkers of Alzheimer's disease: a large case-control study in mainland China

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2022-01-09 Biomarkers

    Most genetic studies concerning risk genes in Alzheimer's disease (AD) are from Caucasian populations, whereas the data remain limited in the Chinese population.

  4. Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Journal of Alzheimer's disease : JAD 2020-01-01 Biomarkers

    In this sample, the high-throughput blood Aβ assay was not able to distinguish well between AD patients and controls.

  5. Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. PloS one 2018-02-08 Biomarkers

    Inner retina in Alzheimer's Disease (AD) may experience neuroinflammation resulting in atrophy.

  6. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Journal of Alzheimer's disease : JAD 2017-01-01 Biomarkers

    Type 2 diabetes is associated with altered plasma concentrations of Aβ peptides and is an important source of variation that needs to be taken into account when considering plasma Aβ peptides as biomarkers for Alzheimer's disease.

All topic tags with their study counts